Skip to contentSkip to Braille Studio

Library / Laws / 116th Congress / Senate Bills / S. 340

S. 340

To promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products.

Print stageDateSize⠃
Placed on Calendar (Senate)—20.5K⠃⠗⠋